|
|
|
Novartis shares higher after J&J recalls
May 12, 2011
Recalls at Johnson & Johnson(JNJ) mean big profit for Novartis (NVS). According to Chief Financial Officer Jon Symonds, he said the company's is benefitting in the consumer drug division and Novartis is reportedly interested in buying other consumer brands.Novartis shares are up 0.95%, or $0.57, to $60.69.
|
|
|